Daniela Marasco Selected Research

Proteins (Proteins, Gene)

6/2023	Ruthenium complexes bearing glucosyl ligands are able to inhibit the amyloid aggregation of short histidine-peptides.
10/2022	Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.
1/2022	Type C mutation of nucleophosmin 1 acute myeloid leukemia: Consequences of intrinsic disorder.
10/2021	Type F mutation of nucleophosmin 1 Acute Myeloid Leukemia: A tale of disorder and aggregation.
1/2021	Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives.
1/2021	Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia.
1/2019	Streptococcal Collagen-like Protein 1 Binds Wound Fibronectin: Implications in Pathogen Targeting.
2/2017	Insights into amyloid-like aggregation of H2 region of the C-terminal domain of nucleophosmin.
9/2016	Destabilisation, aggregation, toxicity and cytosolic mislocalisation of nucleophosmin regions associated with acute myeloid leukemia.
5/2016	Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Marasco Research Topics

Disease

31	Neoplasms (Cancer) 12/2023 - 12/2008
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 01/2013
10	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2023 - 01/2013
7	Inflammation (Inflammations) 04/2022 - 12/2008
7	Neuroblastoma 03/2021 - 09/2015
6	Nervous System Diseases (Neurological Disorders) 08/2020 - 01/2016
5	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 02/2007
4	Triple Negative Breast Neoplasms 12/2023 - 07/2012
4	Infections 06/2020 - 07/2011
4	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2008
4	Type 2 Diabetes Mellitus (MODY) 05/2011 - 06/2008
3	Atherosclerosis 08/2020 - 11/2014
3	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2010
3	Genomic Instability 05/2016 - 04/2008
3	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 07/2005
3	Insulin Resistance 05/2011 - 08/2008
2	Tuberculosis (Tuberculoses) 06/2020 - 07/2014
2	Wounds and Injuries (Trauma) 01/2019 - 07/2014
2	Multiple Sclerosis 04/2017 - 01/2016
2	Parkinson Disease (Parkinson's Disease) 01/2016 - 08/2010
2	Amyloid Plaque 01/2013 - 02/2007
1	Proteostasis Deficiencies 05/2024
1	Pathologic Neovascularization 03/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Atherosclerotic Plaque (Atheroma) 08/2020
1	COVID-19 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Melanoma (Melanoma, Malignant) 04/2017
1	Prostatic Neoplasms (Prostate Cancer) 09/2016
1	Carcinoma (Carcinomatosis) 05/2016
1	Stroke (Strokes) 01/2016
1	Huntington Disease (Huntington's Disease) 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Carcinogenesis 02/2014
1	Pulmonary Arterial Hypertension 01/2014

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 06/2023 - 04/2008
16	Peptides (Polypeptides)IBA 06/2023 - 07/2005
14	NucleophosminIBA 11/2022 - 09/2015
11	Amyloid (Amyloid Fibrils)IBA 05/2024 - 02/2017
6	CytokinesIBA 04/2022 - 01/2014
6	EphA2 ReceptorIBA 01/2020 - 03/2012
4	LipidsIBA 08/2020 - 11/2014
4	CannabinoidsIBA 04/2017 - 01/2016
4	EndonucleasesIBA 05/2016 - 07/2012
3	MetalsIBA 05/2024 - 06/2020
3	PeptidomimeticsIBA 08/2020 - 01/2016
3	EndocannabinoidsIBA 06/2016 - 01/2016
3	phospholipase D1IBA 05/2011 - 08/2008
3	PhosphoproteinsIBA 05/2011 - 08/2008
2	LigandsIBA 05/2024 - 09/2017
2	Nuclear Proteins (Protein, Nuclear)IBA 11/2022 - 12/2020
2	Suppressor of Cytokine Signaling 3 ProteinIBA 04/2022 - 05/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2020 - 01/2019
2	Mitochondrial Precursor Protein Import Complex ProteinsIBA 10/2018 - 12/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2017 - 11/2014
2	Interleukin-22 (IL-22)IBA 07/2017 - 04/2017
2	Prion ProteinsIBA 01/2013 - 02/2007
2	Insulin (Novolin)FDA Link 10/2010 - 02/2010
2	Amyloid beta-PeptidesIBA 02/2009 - 02/2007
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2024
1	enniatinsIBA 12/2023
1	AnticoagulantsIBA 11/2022
1	NucleolinIBA 11/2022
1	GlycoconjugatesIBA 02/2022
1	AntioxidantsIBA 08/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2020
1	Janus KinasesIBA 08/2020
1	Coordination ComplexesIBA 06/2020
1	Amyloidogenic ProteinsIBA 01/2020
1	Erythropoietin FDA Link 01/2020
1	VaccinesIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	Erythromycin (Erycette)FDA LinkGeneric 01/2019
1	CollagenIBA 01/2019
1	Penicillins (Penicillin)FDA Link 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	HydrocarbonsIBA 10/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2018
1	Therapeutic UsesIBA 09/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	Ephrin-A2 (Ephrin A2)IBA 09/2017
1	Interleukin-10 (Interleukin 10)IBA 07/2017
1	CB2 Cannabinoid ReceptorIBA 04/2017
1	Intrinsically Disordered ProteinsIBA 09/2016
1	Saline SolutionIBA 05/2016
1	liposomal doxorubicin (Doxil)FDA Link 05/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	BromidesIBA 09/2015
1	EstersIBA 07/2014
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 07/2014
1	EnzymesIBA 07/2014
1	ApolipoproteinsIBA 07/2014
1	OxysterolsIBA 07/2014
1	Sirtuin 1IBA 02/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014

Therapy/Procedure

12	Therapeutics 05/2024 - 08/2010
1	Immunotherapy 12/2023
1	Role Playing (Playing, Role) 01/2019